Have you been suffering with IBS-C?
Irritable Bowel Syndrome:
IBS is the most common disorder seen by gastroenterologists and is characterized by abdominal pain associated with changes in bowel patterns, such as diarrhea and/or constipation.
About the Ardelyx study:
The purpose of this study is to evaluate the efficacy and safety of the investigational drug, Tenapanor for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). If you qualify for this research study, you will have the opportunity to try this medication. You will also receive study-related care at no charge. If you’re interested, please give us a call us at 941-9965.
If you take part in the study, you will receive at no charge:
- Investigational medication
- Study-related care from a local doctor
You may be eligible to participate if you:
- Are at least 18 to 75 years of age
- Have you been diagnosed with IBS-C
For more specific information on our studies please call us at 941-9965.